\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 18, 2009 6:52 AM EST \n\n \n StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc. - GlobeNewswire\n \n \n | \n\n \n\n \n\n \n\n Nov 13, 2009 6:49 AM EST \n\n \n RidgewaterEquity.com Free Fundamental Sector & Market Research on SWHC, RVBD, SYNA, ARNA, CIEN and ATVI - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 09, 2009 7:07 PM EST \n\n \n Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 4:08 PM EST \n\n \n Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009 - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 5:30 AM EST \n\n \n Unbiased Analysis on PHM, PPL, RT, RAD, ARNA and GNVC Posted on WallStSense.com - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 03, 2009 5:00 PM EST \n\n \n Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 27, 2009 10:40 AM EDT \n\n \n New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");